ADAR1 Capital Management »

Corteva shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Corteva (CTVA) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Corteva

Tip: Access up to 7 years of quarterly data

All positions including Corteva held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corteva by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.2M 37k 57.67
2023-12-31 $2.8M 58k 47.92

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Corteva

Vanguard Group
BlackRock
BlackRock
State Street Corporation
Capital Research and Management Company - Division 3
Reed Conner & Birdwell
Geode Capital Management
Franklin Resources
Nuveen Asset Management
Harris Associates L.P
Massachusetts Financial Services
Henderson Group
Northern Trust
Independent Franchise Partners
Invesco

View all funds holding Corteva